The combination therapy also proved safe, with only about 6% of women needing to stop taking the drug due to side effects, researchers said. Both imlunestrant and Verzenio are taken as pills, ...
The visionary behind TrackOlap- Udit Agarwal, The Founder & CEO, is a dynamic entrepreneur passionate about revolutionizing business efficiency through technology. Under his leadership, TrackOlap has ...
Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ...
Epinephrine can temporarily exacerbate the underlying condition or increase symptoms in patients with the following: hyperthyroidism, Parkinson’s disease, diabetes, renal impairment ... These are not ...